OSM Industry Intel • Summer 2026 The Brain’s Immune Cells Get Stuck in Attack Mode. The Fix Is Not More Antioxidant. It Is the Right Amount. A new Frontiers in Nutrition review reframes neuroprotection around microglial immune state and a dose-response curve that is shaped like an upside-down U. The implication for formulators is uncomfortable […]
Learn More
OSM Industry Intel • Spring 2026 The NIH Just Tested 8 Longevity Compounds. All 8 Failed. The Reason Should Change How You Formulate. The gold-standard longevity screen posted a clean sweep of nulls in 2026, including a compound that passed the same test three years ago. The dose gap between those two results is the […]
Learn More
OSM Industry Intel • Spring 2026 The Phospholipid Shift: Why Your Liposomal “Carrier” Is Now Your Second Active Ingredient New market data shows phosphatidylcholine is being repositioned from delivery material to functional co-active. Here is what that means for pricing, positioning, and your next product label. If you manufacture or sell a liposomal supplement, you […]
Learn More
OSM Industry Intel • Spring 2026 Liposomal Delivery for Skin Repair: What New Wound Healing Research Means for Topical Supplement Brands A major 2026 review maps the clinical progress of liposome-based delivery systems for skin wound healing. Here is why topical supplement brands should be paying close attention. Most topical supplements share a fundamental problem. […]
Learn More
OSM Industry Intel • Spring 2026 Liposomal Technology: How It Works, Why It Matters, and Where Your Next Product Line Fits In Liposomal delivery is reshaping how consumers think about supplement absorption. Here is a practical breakdown of the science, the market opportunity, and the formats worth building around. Here is the uncomfortable truth about […]
Learn More